Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapy
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with few effective treatment options. This study investigates the prognostic significance of claudin 18.2 (CLDN18.2), isocitrate dehydrogenase-1 (IDH1) expression, and the neutrophil-to-... ...
